- You are here: Home
- Services
- Drug Toxicity Services
- In Vitro Genotoxicity
Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
In Vitro Genotoxicity
Creative Bioarray offers a series of genotoxicity tests to identify chemicals that can cause genetic alterations in cells following the OECD test guidelines, including bacterial reverse mutation test OECD 471 (also known as Ames test), in vitro mammalian chromosomal aberration test OECD 473, in vitro mammalian cell micronucleus test OECD 487, in vitro gene mutation assays OECD 490, as well as other genotoxicity assays such as in vitro comet assay and genotoxicity screening.
Genotoxicity, compared to other types of toxicity, may result in severe consequences that can be amplified and inherited after exceptionally long periods following exposure. Even DNA damage that occurs in a single cell caused by genotoxic drugs at low exposure can cause unexpected severe consequences in the long run.
Genotoxicity includes mutagenicity that involves alterations in the DNA structure, as well as DNA damage that may not result in permanent alterations in the DNA structure. Therefore, genotoxicity studies include tests that detect gene mutations, structural and numerical chromosomal aberrations and abnormalities, as well as tests that evaluates induced DNA damages resulted from DNA strand breaks and DNA adducts.
Fig 1. An overview of types of DNA damage
In order to identify genotoxic chemicals early in the drug development process, Creative Bioarray has developed a variety of in vitro genotoxicity tests, including but not limited to:
• | Bacterial reverse mutation test OECD 471 |
• | In vitro mammalian chromosomal aberration test OECD 473 |
• | In vitro mammalian cell micronucleus test OECD 487 |
• | In vitro gene mutation tests OECD 490 |
• | In vitro comet assay |
• | Genotoxicity screening |
Creative Bioarray, having gained deep knowledge and experience in toxicological research and compound safety evaluation throughout the years, is the first-choice partner for consulting and performing in vitro genotoxicity assays. We also provide in vitro toxicity assays on other tissues and organs. If you have any special needs or questions regarding our services, please feel free to contact us to get support from our experienced experts. We look forward to working with you in the near future.
References
- Helleday, Thomas, Saeed Eshtad, and Serena Nik-Zainal. "Mechanisms underlying mutational signatures in human cancers." Nature Reviews Genetics 15.9 (2014): 585-598.
- Žegura, Bojana, and Metka Filipič. Application of in vitro comet assay for genotoxicity testing. Humana Press, 2004.
Explore Other Options
For research use only. Not for any other purpose.